Is metabolic syndrome a risk factor for suboptimal response to ADT?

Metabolic syndrome has been implicated in the development of prostate cancer, but there have been no published data on whether it affects the effectiveness of androgen deprivation therapy (ADT).

Metabolic syndrome, race, and risk for prostate cancer

Metabolic syndrome is increasingly prevalent in the USA and in other parts of the “westernized” world and consists of a cluster of conditions that are known risk factors for cardiovascular disease (obesity, high cholesterol levels, pre-diabetes, etc.). Several recent reports have also linked metabolic syndrome to prostate cancer — but have not had racially diverse [...]

The news report: Thursday, April 9, 2009

Today’s news reports address: The association between metabolic syndrome and prostate cancer The association between health habits (smoking, drinking, and exercise) and prostate cancer risk The use of MRI to project risk of disease recurrence post-surgery Another possible long-term drug development lead

Follow

Get every new post delivered to your Inbox.

Join 269 other followers